Safer Medicines - putting patient safety first

Putting patient safety first

Lectures and talks at scientific conferences

Kenna, G. Overcoming obstacles to human-relevant science. WIST 2nd Congress: Science instead of animals. Cologne, Germany, October 27, 2018 WIST Cologne slides https://www.wist-kongress.de/programm 

Kenna, G. Pharmacokinetics and ADME. ACT Course on Practical Application of Toxicology in Drug Development, 2018. Cambridge, UK. July 23, 2018 ACT_Kenna_2018

Kenna, G. Pharmacokinetics and ADME. ACT Course on Practical Application of Toxicology in Drug Development, 2017. Cambridge, UK. July 19, 2017

Kenna, G. Integrating DILI Hazards to Predict Toxicity of Drug Candidates. Assessment and Management of Human Risk in the Pharmaceutical Industry. 21st North American ISSX Meeting. Rhode Island, USA. September 24, 2017 ISSX21_Kenna_2017

Kenna, G. How non-animal approaches can aid the design and selection of safe drugs. Applied Toxicology Modular MSc Course. Guildford UK. November 11, 2017 Surrey_Kenna_2017

Kenna, G. BSEP inhibition and Drug Induced Liver Injury. SOLVO ‘Meet the Experts: The Transporter Conference. Budapest, Hungary. May 12, 2016 SOLVO_GK slides_09052016

Kenna, G.  Drug induced Liver Injury (DILI): What is the Problem? 11th International ISSX Meeting. Busan, South Korea. June 12, 2016 ISSX_2016_KennaDILI_1

Kenna, G. Integrating DILI hazards enables prediction, assessment and management of human risk. 11th International ISSX Meeting. Busan, South Korea, June 12, 2016 ISSX_2016_KennaDILI_2

Kenna, G. Pharmacokinetics and ADME ACT Course on Practical Application of Toxicology in Drug Development, 2016. Cambridge, UK. July 13, 2016 ACT_2016_GK slides_18052016

Kenna, G. Current trends in BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury. Recommendations to the regulatory agencies concerning BSEP screening in drug discovery and development. PSTC global webinar. July 14, 2016 BSEP_Webinar_Kenna_2016

Kenna, G. Regulating Chemical Safety – the future for animal use. How understanding drug toxicities can aid human chemical safety assessment without using animals. The Lush Prize Conference 2016. London, UK. November 10, 2016 Lush_2016_Kenna

Kenna, G. Integrating data from multiple in vitro methods enable prediction of serious human adverse drug reactions. World Preclinical Congress Europe. Lisbon, Portugal. November 16, 2016 WPC_GK_28102016

15 minute presentation by Dr Bob Coleman at Horizons in Human Cells conference, Edinburgh, May 2014: “Humanising Drug Safety Testing”


24 minute presentation by Dr Bob Coleman at American College of Toxicology annual meeting, San Antonio, Texas, 4 November 2013:

Ensuring safety and efficacy in new medicines – humanising the process


Slide presentation by Dr Bob Coleman at Linz University, Austria, 17th September 2013: “Humanising Toxicity Testing in the 21st Century”.


30 minute presentation by Dr Bob Coleman at the British Toxicology Society Autumn Meeting, 10th September 2012

Share
Follow Us